Toggle Dropdown
Announcements
Projects
Welcome guest
Log in
Loading
Loading...
https://medicaldialogues.in/diabetes-endocrinology/news/imeglimin-lowers-cvd-risk-by-improving-postprandial-flow-mediated-dilation-among-diabetes-patients-106623
0
0
Imeglimin lowers CVD risk by improving postprandial flow-mediated dilation among diabetes patients - Medical Dialogues
2/5/23 at 12:29am
Organization
Medical Dialogues
Author
Dr Kartikeya Kohli
Details
42 words
Summarize
Endocrine Conditions
Diabetes
Health
CVD
Imeglimin
Dialogues Cardiovascular disease
Cardiovascular disease (CVD) is the major cause of mortality in type 2 diabetes and high blood sugar, dyslipidemia, and hypertension are risk factors that contribute significantly to...
Show more
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...